Ioannis Vergados Selected Research

Inclusion Conjunctivitis

12/2013

Evaluation of single-dose azithromycin versus standard azithromycin/doxycycline treatment and clinical assessment of regression course in patients with adult inclusion conjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ioannis Vergados Research Topics

Disease

5	Choroidal Neovascularization 01/2013 - 09/2007
5	Macular Degeneration (Age-Related Maculopathy) 09/2011 - 09/2007
3	Glaucoma 12/2017 - 03/2008
3	Cicatrix (Scar) 12/2017 - 01/2009
3	Hemorrhage 09/2011 - 03/2009
3	Cataract (Cataracts) 03/2011 - 01/2011
3	Macular Edema 06/2010 - 01/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2014 - 05/2011
2	Retinal Vein Occlusion 06/2010 - 12/2009
2	Ocular Hypertension (Glaucoma, Suspect) 03/2008 - 01/2006
1	Inflammation (Inflammations) 12/2017
1	Hypertensive Retinopathy 01/2017
1	Corneal Neovascularization 05/2014
1	Hyperhomocysteinemia 01/2014
1	Inclusion Conjunctivitis 12/2013
1	Chlamydia Infections 12/2013
1	Ocular Toxoplasmosis 01/2013
1	Blindness (Hysterical Blindness) 09/2011
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 08/2011
1	Atrophy 05/2011
1	Polypoidal Choroidal Vasculopathy 03/2011
1	Heart Diseases (Heart Disease) 03/2011
1	Polyps 03/2011
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2011
1	Retinal Perforations 01/2011
1	Vision Disorders (Hemeralopia) 01/2011
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Cysts 09/2010
1	Retinitis 09/2009
1	Uveitis 03/2009
1	Endophthalmitis (Ophthalmia) 02/2009
1	Type II Lattice Corneal Dystrophy 01/2009
1	Meretoja syndrome 01/2009
1	Disease Progression 01/2009
1	Ischemia 02/2008
1	Facial Hemiatrophy (Parry-Romberg Syndrome) 01/2008
1	Papilledema 01/2008
1	Edema (Dropsy) 01/2008
1	Infections 02/2006
1	Hepatitis C 02/2006
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 02/2006
1	Chronic Hepatitis C 02/2006

Drug/Important Bio-Agent (IBA)

9	Ranibizumab (Lucentis)FDA Link 05/2014 - 01/2009
6	Retinaldehyde (Retinal)IBA 01/2015 - 01/2006
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2011 - 09/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 01/2009
2	Retinal Pigments (Pigments, Visual)IBA 06/2011 - 05/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2009 - 01/2008
2	Bevacizumab (Avastin)FDA Link 02/2008 - 09/2007
1	Infliximab (Remicade)FDA Link 12/2017
1	Monoclonal AntibodiesIBA 12/2017
1	Biological ProductsIBA 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	CytokinesIBA 12/2017
1	AntioxidantsIBA 01/2017
1	AlkaliesIBA 05/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2014
1	HomocysteineIBA 01/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	VitaminsIBA 01/2014
1	Doxycycline (Periostat)FDA LinkGeneric 12/2013
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2013
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 08/2011
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2011
1	Cortisone FDA Link 03/2011
1	exemestane (Aromasin)FDA Link 09/2010
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 09/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2009
1	Pharmaceutical PreparationsIBA 03/2009
1	Moxifloxacin (Avelox)FDA Link 02/2009
1	Therapeutic UsesIBA 01/2009
1	Verteporfin (Visudyne)FDA Link 02/2008
1	Interferon-alpha (Interferon Alfa)IBA 02/2006
1	InterferonsIBA 02/2006
1	Ribavirin (Virazole)FDA LinkGeneric 02/2006

Therapy/Procedure

5	Intravitreal Injections 09/2011 - 09/2007
3	Injections 06/2011 - 03/2009
3	Photochemotherapy (Photodynamic Therapy) 03/2011 - 09/2007
2	Traction 01/2013 - 01/2011
2	Phacoemulsification 01/2011 - 01/2009
2	Lasers (Laser) 03/2008 - 01/2006
1	Filtering Surgery 12/2017
1	Trabeculectomy (Trabeculoplasty) 12/2017
1	Cautery 05/2014
1	Retreatment 03/2011
1	Eyeglasses (Spectacles) 03/2011
1	Drug Therapy (Chemotherapy) 09/2010
1	Therapeutics 02/2006